Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ANAEROBIC BLOOD AGAR (CDC FORMULATION)

K-Number: K871089 · 1987-04-03

ApplicantbioMerieux, Inc.
Decision Date1987-04-03
Product CodeJSG
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ANAEROBIC BLOOD AGAR (CDC FORMULATION) is the device name listed in this FDA 510(k) record. The listed applicant is bioMerieux, Inc.. It received FDA 510(k) clearance on 1987-04-03 under 510(k) number K871089. The device is classified under product code JSG. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ANAEROBIC BLOOD AGAR (CDC FORMULATION)?

ANAEROBIC BLOOD AGAR (CDC FORMULATION) is a medical device that received FDA 510(k) clearance on 1987-04-03. The listed applicant is bioMerieux, Inc.. The 510(k) number is K871089.

When did ANAEROBIC BLOOD AGAR (CDC FORMULATION) receive FDA 510(k) clearance?

ANAEROBIC BLOOD AGAR (CDC FORMULATION) received FDA 510(k) clearance on 1987-04-03, under 510(k) number K871089.

Who is the listed applicant for ANAEROBIC BLOOD AGAR (CDC FORMULATION)?

The FDA 510(k) record lists bioMerieux, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ANAEROBIC BLOOD AGAR (CDC FORMULATION)?

The FDA product code for ANAEROBIC BLOOD AGAR (CDC FORMULATION) is JSG.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing bioMerieux, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260160VITEK REVEAL GN AST Assay and VITEK REVEAL AST SystemK260282VITEK 2 AST-Streptococcus Inducible Clindamycin ResistanceK251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)K234012VITEK COMPACT PROK232967VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)K232963VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)

View all 248 devices →

Related Devices (Code: JSG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K882495THIOGLYCOLLATE BROTH W/VITA. K & HEMIN - #T3007Lakewood Biochemical Co., Inc.K881564TRYPTOSE BLOOD AGAR BASE W/YEAST EXTRACTAcumedia Manufacturers, Inc.K881557TRYPTONEAcumedia Manufacturers, Inc.K881558TRYPTOSE AGARAcumedia Manufacturers, Inc.K881550OF BASAL MEDIUMAcumedia Manufacturers, Inc.K881533BLOOD AGAR BASE NO. 2Acumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑